Le Lézard
Classified in: Health
Subjects: PARTNERSHIPS, HEALTH, GOVERNMENT CONTRACTS, MISCELLANEOUS

ALBERTA PARTNERSHIP STRENGTHENS THE LINK BETWEEN NUTRITION AND DIGESTIVE DISEASE


Edmonton, AB, Oct. 18, 2019 (GLOBE NEWSWIRE) -- A new provincial collaboration has been formed to improve the long-term health outcomes, quality of life, and economic prosperity for Albertans suffering with digestive diseases. The University Hospital Foundation (UHF), Ministry of Alberta Economic Development, Trade and Tourism, and Takeda Canada through the Calgary Health Trust (CHT), have jointly invested $1.7 million into the partnership. Alberta's Collaboration of Excellence for Nutrition in Digestive Diseases (AsCEND) announced the official launch today at the Western Canadian Nutrition Conference in Edmonton, Alberta.
 
From prevention programs, to acute treatments that enhance the quality of life for survivors, this collaboration is funding cutting edge research, and taking an innovative and comprehensive approach to understand the role nutrition can play in numerous types of digestive diseases. The internationally recognized researchers are performing studies on three key gastrointestinal conditions: inflammatory bowel disease, intestinal failure, and cirrhosis.
 
In the past several decades, prevalence of Inflammatory Bowel Diseases (IBD) has rapidly increased. Canada has one of the highest rates in the world at 1 in 360 Canadians living with the chronic disease. Dr. Maitreyi Raman is the Medical Director for the AsCEND collaboration. "There is currently no cure for IBD." said Dr. Raman. "Patients describe IBD or Crohn's Disease as an inner demon that's impossible to defeat, and are bombarded with medications after diagnosis. There is potentially new hope for disease management in patients with IBD using personalized anti-inflammatory diet therapy, which improves diet quality and meets nutrient recommendations."  
 
The provincial partnership for Alberta's Collaborations of Excellence for Nutrition in Digestive Diseases (AsCEND) will support education and training, post-graduate physician nutrition fellowships, and clinical patient support and development, focused on three main pillars:

"At Takeda, we are driven to make a real difference in the lives of Canadians with digestive diseases," said Gamze Yüceland, General Manager for Takeda Canada. "We are excited to be part of the AsCEND collaboration which aims to make a difference through a comprehensive nutrition-based approach to achieve better health and a brighter future for Canadian patients."

"Alberta is home to world-leading healthcare and research teams in gastroenterology, nutrition, and inflammatory bowel diseases. The University Hospital Foundation is proud to be a partner in this collaboration as we know it will have a positive impact on the health of Albertans living with these conditions," said Christy Holtby, Interim CEO with the University Hospital Foundation. "We're so grateful for the support from community members through our Foundation to help fund this ground-breaking collaboration."

"This partnership is an excellent example of how collaboration between the public and private sectors, and our foundations in both Edmonton and Calgary can work together to make a transformational impact on healthcare outcomes for Albertans," added Mike Meldrum, CEO of Calgary Health Trust. "We are pleased to have the opportunity to work alongside University Hospital Foundation and Takeda Canada in bringing this opportunity to Alberta."

About the AsCEND Partners 

University Hospital Foundation

The University Hospital Foundation raises and manages funds to advance patient care, research and healthcare education at the University of Alberta Hospital, the Mazankowski Alberta Heart Institute and the Kaye Edmonton Clinic. Through Strategic Partnerships, the University Hospital Foundation brings together industry, the public sector, and philanthropy to fund research and find solutions that impact the health of all Albertans. www.GivetoUHF.ca
 
Government of Alberta

The Ministry of Alberta Economic Development, Trade and Tourism focuses on economic growth and diversification by supporting innovation and research; expanding access to capital for small and medium-sized enterprises; promoting trade, investment and market access initiatives; and leading Alberta's negotiations on trade agreements. http://economic.alberta.ca 
 
Takeda Canada

Takeda Canada headquarters is currently located in Oakville, Ontario and is the Canadian subsidiary of Takeda Pharmaceutical Company Limited. Takeda Canada is delivering better health for Canadians through leading innovations in gastroenterology, oncology, neuroscience, and rare diseases. Additional information about Takeda Canada is available at www.takeda.com/en-ca.

Calgary Health Trust

Calgary Health Trust raises money to advance healthcare within Calgary. Funds raised benefit Foothills Medical Centre, Peter Lougheed Centre, Rockyview General Hospital, South Health Campus, many community health programs and 12 Carewest care centres in our community. For more information about Calgary Health Trust and its strategic priorities, visit www.calgaryhealthtrust.ca.


These press releases may also interest you

at 09:13
Methodist Le Bonheur Healthcare announced Methodist University Hospital earned top recognition by Money magazine as one of the Best U.S. Hospitals for Cardiac Care. The Memphis-based healthcare system's academic flagship landed 15th out of 75 and is...

at 09:06
Avicenna.AI, a leading medical imaging AI company, has received Medical Device Regulation (MDR) certificate for five of its algorithms from certification body BSI Medical Devices. This development means the company's product portfolio is fully...

at 09:03
Insmed Incorporated , a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that additional positive results from the ASPEN...

at 09:00
In March 2024, dairy cows in Texas were found to be infected with highly pathogenic avian flu, or H5N1 bird flu, in the first known case of the virus spreading to cattle. Since then, H5N1 has been found in about 200 animals?and 3 people?across 12...

at 09:00
Emmaus Life Sciences, Inc. , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the year ended December 31, 2023....

at 09:00
Global health company The Cigna Group will release its second quarter 2024 financial results on Thursday, August 1, 2024, and will host a conference call the same day....



News published on and distributed by: